Berry Genomics Co Ltd Class A 000710
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 8.58
- Day Range
- CNY 8.47–9.09
- 52-Week Range
- CNY 5.40–16.48
- Bid/Ask
- CNY 8.69 / CNY 8.70
- Market Cap
- CNY 3.08 Bil
- Volume/Avg
- 26.9 Mil / 20.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.76
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Berry Genomics Co Ltd is an innovative biotechnology company. It providess gene sequencing detection equipment and services.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,438
- Website
- http://www.berrygenomics.com
Comparables
Valuation
Metric
|
000710
|
688253
|
688068
|
---|---|---|---|
Price/Earnings (Normalized) | — | 20.72 | 13.55 |
Price/Book Value | 1.62 | 2.47 | 0.80 |
Price/Sales | 2.76 | 7.90 | 2.78 |
Price/Cash Flow | 28.88 | 11.96 | — |
Price/Earnings
000710
688253
688068
Financial Strength
Metric
|
000710
|
688253
|
688068
|
---|---|---|---|
Quick Ratio | 1.63 | 10.60 | 3.49 |
Current Ratio | 2.02 | 11.04 | 5.51 |
Interest Coverage | — | 1,693.02 | — |
Quick Ratio
000710
688253
688068
Profitability
Metric
|
000710
|
688253
|
688068
|
---|---|---|---|
Return on Assets (Normalized) | −2.24% | 4.47% | −3.48% |
Return on Equity (Normalized) | −3.20% | 4.81% | −3.84% |
Return on Invested Capital (Normalized) | −2.73% | 4.51% | −4.65% |
Return on Assets
000710
688253
688068
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Cnbvclyptt | Dvfqb | $566.6 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Gvwrnlml | Pvrqjc | $102.4 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Dxdfjbmq | Sddpks | $98.3 Bil | |
MRNA
| Moderna Inc | Cbsnppjd | Mbjt | $42.7 Bil | |
ARGX
| argenx SE ADR | Fcfkhjcqx | Qyzl | $22.2 Bil | |
BNTX
| BioNTech SE ADR | Xzyklmy | Hcwx | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Lyzwlnp | Tkbcpc | $18.6 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Kwnchgl | Xvbnqx | $15.6 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jtbrdmsxb | Mdvtw | $12.7 Bil | |
INCY
| Incyte Corp | Grqnzmlsj | Vqbtff | $11.8 Bil |